Oral Anti-Diabetic Drug Market Expands As Healthcare Providers Focus On Early Intervention And Prevention Market Trends & Business Updates
The global Oral Anti-Diabetic Drug market is poised for substantial growth, driven by increasing diabetes cases, advancements ...
5 Supplements You Shouldn’t Take If You’re Taking a GLP-1 Medication, According to Experts
Similarly, zinc may contribute to GI issues like diarrhea or cramping. Many immune-supporting supplements combine vitamin C ...
Yahoo Finance2d
CORRECTING and REPLACING Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity
Over the past six months, Altasciences has completed nonclinical work for MET-233i, an ultra-long-acting injectable amylin ...
News Medical2d
Expert explores the expanding applications of GLP1 therapies
Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...
emjreviews.com2d
Could GLP-1 Drugs Reduce Alcohol Consumption?
A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...
The “Holiday Pause” For GLP-1s Is Quickly Approaching — but Is It Safe?
Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...
News Medical3d
GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events
Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.
Daily3d
No significant benefit of IV exenatide in reducing complications during cardiac surgery, finds GLORIOUS trial
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
Medical News Today3d
How to preserve muscle mass on weight-loss drugs like Wegovy
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
Medscape3d
GLP-1 Labels Don’t Reflect Trial Exclusions
Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...
Lexaria Bioscience’s Promising Outlook on GLP-1 Drugs
Lexaria Bioscience (LEXX) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now ...
Becker's Hospital Review4d
6 GLP-1 study findings to know
Here are six recent GLP-1 studies: 1. The use of Ozempic and Wegovy reduced healthcare costs for overweight or obese patients with heart failure or atherosclerotic cardiovascular disease, according to ...